MRI-Based Radiomic Signature as a Prognostic Biomarker for HER2-Positive Invasive Breast Cancer Treated with NAC

PURPOSE: To identify MRI-based radiomics signature (Rad-score) as a biomarker of risk stratification for disease-free survival (DFS) in patients with HER2-positive invasive breast cancer treated with trastuzumab-based neoadjuvant chemotherapy (NAC) and establish a radiomics-clinicoradiologic-based n...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qin, Xiao, Qin, Li, Jianwei, Duan, Shaofeng, Wang, He, Gu, Yajia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602910/
https://www.ncbi.nlm.nih.gov/pubmed/33149669
http://dx.doi.org/10.2147/CMAR.S271876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602910/
https://www.ncbi.nlm.nih.gov/pubmed/33149669
http://dx.doi.org/10.2147/CMAR.S271876

Ejemplares similares